Maureen Newman
About Maureen Newman
Maureen Newman is a Senior Scientist at Nautilus Biotechnology, where she has worked since 2022. She has extensive experience in bioanalytical assay development and holds a PhD in Biomedical Engineering from the University of Rochester.
Work at Nautilus Biotechnology
Maureen Newman has been employed as a Senior Scientist at Nautilus Biotechnology since 2022. In this role, she focuses on developing a platform that quantifies single protein molecules at a large scale. Her work contributes to advancing the company's mission in biotechnology, particularly in the area of protein quantification.
Previous Experience at Surrozen
Before joining Nautilus Biotechnology, Maureen Newman worked at Surrozen as a Senior Scientist in Bioanalytical Assay Development from 2018 to 2022. During her tenure, she designed and qualified pharmacokinetic (PK), anti-drug antibody (ADA), and biomarker assays for non-GLP toxicology studies. She also led the bioanalytical strategy for bispecific antibodies and fusion proteins, supporting first-in-human studies.
Educational Background
Maureen Newman studied at the University of Rochester, where she earned a Doctor of Philosophy (PhD) in Biomedical Engineering from 2013 to 2018. Additionally, she completed two Master of Science (MS) degrees in Biomedical Engineering and Technical Entrepreneurship and Management between 2013 and 2015. She also holds a Bachelor of Science (BS) in Biomedical Engineering from Rensselaer Polytechnic Institute, obtained from 2009 to 2013.
Early Career and Research Experience
Maureen Newman began her career with research roles at the University of Rochester, where she served as a Summer Scholar in the Therapeutic Biomaterials Laboratory in 2012. She also worked as a PhD Candidate and Research Assistant from 2013 to 2018. Additionally, she was a Community Connector at Upstate Venture Connect for ten months in 2014 to 2015 and a Senior Science & Research Columnist at BioNews Services from 2014 to 2016.
Research Focus and Motivation
Maureen Newman is motivated by the potential to develop technologies that quantify single protein molecules. Her research interests align with her work at Nautilus Biotechnology, where she aims to understand the unknown in protein quantification and make it beneficial for scientific advancement.